EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Pronounced heterogeneity in long-term variability of bone turnover markers in patients with breast cancer



Pronounced heterogeneity in long-term variability of bone turnover markers in patients with breast cancer



Journal of Bone & Mineral Research 17(Suppl 1): S316, September




(PDF emailed within 1 workday: $29.90)

Accession: 035571118

Download citation: RISBibTeXText



Related references

Long-term variability of bone turnover markers in patients with non-metastatic breast cancer. Clinical Laboratory 48(11-12): 579-582, 2002

Markers of bone turnover do not predict bone metastases during long-term follow-up of breast cancer patients. Journal of Bone & Mineral Research 17(Suppl 1): S310, September, 2002

Bone mineral density and bone turnover markers in patients on long-term suppressive levothyroxine therapy for differentiated thyroid cancer. Annals of Surgical Treatment and Research 86(2): 55-60, 2014

Markers of bone turnover in metastatic breast cancer patients having progressed on tamoxifen Short term effect of further treatment with either exemestane or megestrol acetate. European Journal of Cancer 37(Supplement 6): S193-S194, October, 2001

Markers of bone turnover (ICTP, NTX) and serum matrix metalloproteinase 1 (MMP1) as prognostic markers in breast cancer patients (BC) with bone metastases (BM) treated with bisphosphonates (BP). Journal of Clinical Oncology 26(15_suppl): 1024-1024, 2016

Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study. Journal of Bone and Mineral Research 18(10): 1789-1794, 2003

Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical utility The OFELY Study. Journal of Bone & Mineral Research 17(Suppl 1): S299, September, 2002

Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases. Breast Cancer (): -, 2016

Changes in biochemical markers of bone turnover in breast cancer patients with bone metastases. European Journal of Cancer 34(SUPPL 2): S10, 1998

Biochemical markers of bone turnover in breast cancer patients with bone metastases: a preliminary report. Japanese Journal of Clinical Oncology 29(1): 16-22, 1999

Circadian rhythm of bone turnover markers in breast cancer patients with bone metastases and in control subjects. Journal of Clinical Oncology 23(16_suppl): 737-737, 2016

Biochemical markers of bone turnover. New aspect. Biochemical markers of bone turnover in long term treatment with bisphosphonate. Clinical Calcium 19(8): 1179-1185, 2009

Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases. British Journal of Cancer 98(11): 1753-1758, 2008

Influence of adjuvant tamoxifen treatment on bone mineral density and bone turnover markers in postmenopausal breast cancer patients in Japan. Cancer Letters 186(2): 223-230, December 5, 2002